Conventional Radiotherapy with Concurrent Weekly Cisplatin in Locally Advanced Head and Neck Cancers of Squamous Cell Origin - a Single Institution Experience |
Dimri, Kislay
(Department of Radiotherapy, Government Medical College)
Pandey, Awadhesh Kumar (Department of Radiotherapy, Government Medical College) Trehan, Romeeta (Department of Radiotherapy, Government Medical College) Rai, Bhavana (Department of Radiotherapy, Institute of Medical Education and Research) Kumar, Anup (Rajendra Institute of Medical Sciences) |
1 | Adelstein DJ, Li Y, Adams GL, et al (2003). An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemo-radiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol, 21, 92-8. DOI ScienceOn |
2 | Bernier J, Domenge C, Ozsahin M, et al (2004). Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med, 350, 1945-52. DOI ScienceOn |
3 | Brizel DM, Esclamado R (2006). Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum. J Clin Oncol, 24, 2612-17. DOI ScienceOn |
4 | Chan AT, Leung SF, Ngan RK, et al (2005). Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in loco-regionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst, 6, 536-9. |
5 | Cooper JS, Pajak TF, Forastiere AA, et al (2004). Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med, 350, 1937-44. DOI ScienceOn |
6 | Cox JD, Stetz J, Pajak TF (1995). Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys, 31, 1341-6. DOI ScienceOn |
7 | Forastiere AA, Goepfert H, Maor M, et al (2003). Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med, 349, 2091-98. DOI ScienceOn |
8 | Fountzilas G, Ciuleanu E, Dafni U, et al (2004). Concomitant radio-chemotherapy vs radiotherapy alone in patients with head and neck cancer. Med Oncol, 21, 95-107. DOI ScienceOn |
9 | Geeta SN, Padmanabhan TK, Samuel J, et al (2006). Comparison of acute toxicities of two chemotherapy schedules for head and neck cancers. J Cancer Res Ther, 2, 100-4. DOI ScienceOn |
10 | Gorodetsky R, Levy-Agababa F, Mou X, Vexler A (1998). Combination of cisplatin and radiation in cell culture: effect of duration of exposure to drug and timing of irradiation. Int J Cancer, 75, 635-42. DOI |
11 | Gupta T, Agarwal JP, Laskar SG, et al (2009). Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience. Head Neck Oncol, 1, 17. DOI ScienceOn |
12 | Homma A, Inamura N, Oridate N, et al (2011). Concomitant weekly cisplatin and radiotherapy for head and neck cancer. Jpn J Clin Oncol, 41, 980-6 DOI ScienceOn |
13 | Krstevska V, Stojkovski I, Zafirova-Ivanovska B (2012). Concurrent radiochemotherapy in locally-regionally advanced oropharyngeal squamous cell carcinoma: analysis of treatment results and prognostic factors. Radiat Oncol, 7, 78 DOI |
14 | Kumar S, Dimri K, Datta NR, et al (2002). Safety and efficacy of concurrent cisplatin and radiotherapy in inoperable or metastatic squamous cell esophageal cancer. Acta Oncologica, 41, 457-62. DOI |
15 | Kumar S, Dimri K, Khurana R, et al (2007). A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus. Radiother Oncol, 83, 139-47. DOI ScienceOn |
16 | Kumar S, Pandey M, Lal P, et al (2005). Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial. Radiother Oncol, 75, 186-92. DOI ScienceOn |
17 | Pignon JP, Bourhis J, Domenge C, Designe L (2000). Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet, 355, 949-55. DOI ScienceOn |
18 | Myint WK, Ng C, Raaphorst GP (2002). Examining the non-homologous repair process following cisplatin and radiation treatments. Int J Radiat oncol Biol, 78, 417-24. DOI |
19 | Otty Z, Skinner MB, Dass J, et al (2011). Efficacy and tolerability of weekly low-dose cisplatin concurrent with radiotherapy in head and neck cancer patients. Asia Pac J Clin Oncol, 7, 287-92. DOI ScienceOn |
20 | Pala M, Odrazka K, Holeckova P, et al (2012). Definitive radiochemotherapy with weekly cisplatin in patients with head and neck cancer; single institution outcome analysis. J BUON, 17, 471-7. |
21 | Pignon JP, Maitre AL, Bourhis J (2007). Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): An update. Int J Radiat Oncol Biol Phys, 69, 112-4. |
22 | Rose PG, Bundy BN, Watkins EB, et al (1999). Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med, 15, 1144-53. |
23 | Steinmann D, Cerny B, Karstens JH, Bremer M (2009). Chemoradiotherapy with weekly cisplatin 40 mg/ in 103 head-and-neck cancer patients: a cumulative dose-effect analysis. Strahlenther Onkol, 185, 682-8. DOI ScienceOn |
24 | Watkins JM, Zauls AJ, Wahlquist AH, et al (2010). Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer. Laryngoscope, 120, 236-42. DOI ScienceOn |